Medicare Enrolled

Dr. Nehal Gandhi, MD

Rheumatology · Glen Mills, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Mixed engagement
30 LACRUE AVE STE 101, Glen Mills, PA 19342
6105584800
In practice since 2008 (18 years)
NPI: 1295909919 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gandhi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gandhi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gandhi

Dr. Nehal Gandhi is a rheumatology specialist in Glen Mills, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Gandhi performed 902,194 Medicare services across 3,029 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gandhi received a total of $3,905 from 15 pharmaceutical and/or device companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gandhi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 0% volume in PA $3,905 industry payments

Medicare Practice Summary

Medicare Utilization ↗
902,194
Medicare services
Top 0% in PA for rheumatology
3,029
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~50,122 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
507,600 $4 $16
Tocilizumab injection (Actemra) 166,830 $5 $10
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
72,575 $34 $99
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
57,850 $10 $60
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
29,090 $25 $118
Romosozumab injection (Evenity) for osteoporosis 22,470 $8 $25
Denosumab injection (Prolia/Xgeva) 20,040 $18 $39
Joint lubricant injection (TriVisc)
An injection of hyaluronan or a derivative into a joint space. The dose specified is 1 milligram.
7,575 $7 $32
Infliximab-abda biosimilar injection, 10 mg
This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product.
6,750 $30 $123
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
3,089 $62 $204
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
2,712 $1 $15
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
2,197 $106 $370
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,931 $100 $287
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
612 $23 $110
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
426 $63 $244
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
171 $127 $441
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
84 $4 $60
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
83 $11 $68
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
41 $38 $205
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
26 $37 $145
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
24 $1 $20
Tendon or ligament injection
A procedure involving the injection of medication into a tendon or ligament.
18 $40 $159
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.9% high complexity
81.8% medium
0.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,905
Total received (2018-2024)
Avg $558/year across 7 years
Top 44% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
123
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,711 (43.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,570 (40.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$357 (9.1%)
Scientific / Research
Research funding and grants
$267 (6.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$535
2023
$551
2022
$474
2021
$1,691
2020
$20
2019
$137
2018
$498

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$144
Janssen Biotech, Inc.
$138
ABBVIE INC.
$137
Mallinckrodt Hospital Products Inc.
$68
ANI Pharmaceuticals, Inc.
$27
Lilly USA, LLC
$21
Top 3 companies account for 78.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,570
Janssen Biotech, Inc.
$567
ABBVIE INC.
$404
Mallinckrodt Hospital Products Inc.
$310
Amgen Inc.
$251
Lilly USA, LLC
$186
UCB, Inc.
$144
PFIZER INC.
$142
ANI Pharmaceuticals, Inc.
$117
SANOFI-AVENTIS U.S. LLC
$100
E.R. Squibb & Sons, L.L.C.
$43
AbbVie Inc.
$24
Horizon Therapeutics plc
$18
Fresenius Kabi USA, LLC
$16
Horizon Pharma plc
$12
Top 3 companies account for 65.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Bimzelx · COSENTYX · Cimzia · DUEXIS · EVENITY · Enbrel · FORTEO · IDACIO · KEVZARA · KRYSTEXXA · ORENCIA · PURIFIED CORTROPHIN GEL · RINVOQ · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TREMFYA · Tavneos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (44%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Glen Mills?
Compare rheumatologists in the Glen Mills area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
129
Per 100K population
22.4
County median income
$88,576
Nearest hospital
RIDDLE MEMORIAL HOSPITAL
4.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gandhi is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with mixed engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gandhi experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Gandhi performed 507,600 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gandhi receive payments from pharmaceutical companies?
Yes. Dr. Gandhi received a total of $3,905 from 15 companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gandhi's costs compare to other rheumatologists in Glen Mills?
Dr. Gandhi's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gandhi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →